Clinical Trial Update: Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated an HLA-A*2402 restricted peptide vaccine in patients with advanced gastric cancer and has completed, focusing on safety and immunog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HLA-A*2402 restricted peptide vaccine

Snippet

Sponsor: Kinki University | Conditions: Gastric Cancer | Phase 1 | Status: COMPLETED